INTERNATIONAL SYMPOSIUM ON CANCER IMMUNOLOGY AND IMMUNOTHERAPY: 18 DECEMBER 2014
6/11/2014“TRANSLATING BASIC SCIENCE INTO NEXT GENERATION THERAPIES”
Breakthroughs in cancer immunology research have led to the emergence of cancer immunotherapy as a new class of treatment for a variety of malignancies. Amplification of tumor-specific T cells and blockade of T cell inhibitory signals have been demonstrated to eliminate primary and disseminated tumors, conferring durable clinical responses to cancer patients. This international symposium will discuss cutting-edge research topics on the induction and regulation of antitumor T cell immunity as well as the recent advances made in the revolutionary field of cancer immunotherapy.
Program
| 8:15 | Breakfast and welcoming words |
| 9:00 | “Regulation of dendritic cell function by the unfolded protein response”, Fabiola Osorio, PhDTumor Immunology and Immunotherapy LaboratoryFacultad de Medicina, Universidad de Chile, Santiago, Chile. |
| 9:30 | “New generation of cancer DNA vaccines”, Alvaro Lladser, PhDGroup Leader – Gene Immunotherapy LaboratoryFundación Ciencia & Vida, Santiago, Chile. |
| 10:10 | “Biological and therapeutic aspects of a new dendritic cell-based cancer vaccine”, Flavio Salazar, PhDTumor Immunology and Immunotherapy LaboratoryFacultad de Medicina, Universidad de Chile, Santiago, Chile. |
| 10:50 | Coffee break |
| 11:20 | “Th17 cell dynamics in tumor immunity”, Daniela Sauma, PhDImmunology LaboratoryFacultad de Ciencias, Universidad de Chile, Santiago, Chile. |
| 11:50 | “Immune modulation within tumours”, Sergio Quezada, PhDImmune Regulation and Tumour Immunology LaboratoryUniversity College London, Cancer Institute, London, UK. |
| 12:30 | “Cancer Immunotherapy: What we can offer patients and where we need to go”, Mark Selby, PhDDirector, Cell Biology & ImmunologyBristol-Myers Squibb, Milpitas, California, USA. |
| 13:10 | Cocktail |
